Pain · 2020 · 13 citations · 43 references
NursingNeurobiologyNeuroscienceNeuropharmacologyPain MedicinePain ScienceAnalgesiaOpioid AnalgesicsPain NeurobiologyPain NeurosciencePain PhysiologyPain ProcessingAnalgesic EffectsCentral Analgesic MechanismsInsula In Decision MakingInsula ProcessingOpioid Antagonist TherapyOpioid AntagonistsPain Intensity Rating ScalesSecondary Somatosensory Cortex
ABSTRACT: Placebo analgesia is hypothesized to involve top-down engagement of prefrontal regions that access endogenous pain inhibiting opioid pathways. Fibromyalgia (FM) patients have neuroanatomical and neurochemical alterations in pathways relevant to placebo analgesia. Thus, it remains unclear whether placebo analgesic mechanisms would differ in FM patients compared to healthy controls (HCs). Here, using placebo-analgesia-inducing paradigms that included verbal suggestions and conditioning manipulations, we examined whether behavioral and neural placebo analgesic responses differed between 32 FM patients and 46 age- and sex-matched HCs. Participants underwent a manipulation scan, where noxious high and low heat were paired with the control and placebo cream, respectively, and a placebo experimental scan with equal noxious heat temperatures. Before the experimental scan, each participant received saline or naloxone, an opioid receptor antagonist. Across all participants, the placebo condition decreased pain intensity and unpleasantness ratings, decreased activity within the right insula and bilateral secondary somatosensory cortex, and modulated the neurologic pain signature. There were no differences between HCs and FM patients in pain intensity ratings or neural responses during the placebo condition. Despite the perceptual and neural effects of the placebo manipulation, prefrontal circuitry was not activated during the expectation period and the placebo analgesia was unaltered by naloxone, suggesting placebo effects were driven more by conditioning than expectation. Together, these findings suggest that placebo analgesia can occur in both HCs and chronic pain FM patients, without the involvement of opioidergic prefrontal modulatory networks.
43
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Catriona D. Good, Ingrid S. Johnsrude, John Ashburner et al. · NeuroImage · 2001 · 4.6K citations · Full text
Education, Anatomy, Neuroscience +12
Placebo-Induced Changes in fMRI in the Anticipation and Experience of Pain
Tor D. Wager, James K. Rilling, Edward E. Smith et al. · Science · 2004 · 2K citations
An fMRI-Based Neurologic Signature of Physical Pain
Tor D. Wager, Lauren Y. Atlas, Martin A. Lindquist et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text
Medicine, Neurology, Neuroscience +17
Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density
A. Vania Apkarian, Y. Sosa, Sreepadma Sonty et al. · Journal of Neuroscience · 2004 · 1.4K citations · Full text
Medicine, Neurology, Neuroscience +17